Keyphrases
Moderate to Severe
100%
Persistent Asthma
100%
Inverse Agonist
100%
Propranolol
100%
Corticosteroid-sparing
100%
Inhaled Corticosteroids
45%
Confidence Interval
36%
Forced Expiratory Volume in 1 Second (FEV1)
27%
Hydrofluoroalkane
27%
Beclometasone Dipropionate
27%
High Dose
18%
Histamine
18%
PC20
18%
Placebo
9%
Placebo-controlled
9%
Inflammation
9%
Patient-completed
9%
Blood Eosinophils
9%
Exhaled Nitric Oxide
9%
Randomized Double-blind
9%
Asthma Quality of Life Questionnaire
9%
Asthma Symptoms
9%
Anti-inflammatory Effect
9%
Asthma Control Questionnaire
9%
2 Receptor
9%
Airway
9%
Histamine Challenge
9%
Corticosteroid Dose
9%
Airway Hyperresponsiveness
9%
Mean Reduction
9%
Salbutamol
9%
Eosinophil Cationic Protein
9%
Tiotropium
9%
Controlled Crosses
9%
Switch-off
9%
Day Patient
9%
Murine Asthma Model
9%
Post-challenge
9%
Immunology and Microbiology
Asthma
100%
Agonist
100%
Moderate Persistent Asthma
100%
Beclometasone Dipropionate
75%
Dilution
75%
Forced Expiratory Volume
75%
Histamine
75%
Drug Megadose
50%
Low Drug Dose
50%
Exhaled Nitric Oxide
25%
Eosinophil Granulocyte
25%
Antiinflammatory Activity
25%
Salbutamol
25%
Respiratory Tract Allergy
25%
Pharmacology, Toxicology and Pharmaceutical Science
Inverse Agonist
100%
Moderate Persistent Asthma
100%
Propranolol
100%
Asthma
36%
Fluorinated Hydrocarbon
27%
Beclometasone Dipropionate
27%
Histamine
27%
Placebo
18%
Receptor
9%
Nitric Oxide
9%
Inflammation
9%
Antiinflammatory Activity
9%
Salbutamol
9%
Respiratory Tract Allergy
9%
Eosinophil Cationic Protein
9%